Physician profile
Robert D Rabalais
NPI 1083630040
$5,470.72
in general payments reported to CMS, 2019-2025
17 companies · $168 in 2025
The $168 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,631 · 2020: $1,350 · 2021: $385 · 2022: $465 · 2023: $243 · 2024: $230 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $640.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $639.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alon Medical Technology | $1,606.86 | 2019-2023 | |
| Arthrex, INC. | $1,588.98 | 2019-2020 | |
| Horizon Therapeutics Plc | $600.92 | 2019-2022 | |
| Smith+Nephew, INC. | $292.36 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $214.49 | 2019-2024 | Euflexxa |
| Innovation Technologies INC | $170.48 | 2024 | Irrisept |
| Pacira Pharmaceuticals Incorporated | $151.47 | 2021-2023 | Exparel, Zilretta, Iovera |
| Stryker Corporation | $150.63 | 2023-2025 | Mako, Gamma |
| Vericel Corporation | $142.25 | 2019-2023 | Maci |
| Biorez, INC. | $120.24 | 2022 | |
| Organogenesis INC. | $109.52 | 2019 | |
| Pacira Therapeutics, INC. | $89.98 | 2019-2021 | |
| Henry Schein, INC. | $77.55 | 2025 | |
| Medtronic, INC. | $53.83 | 2023-2024 | Aquamantys(Tm), Plasmablade(Tm) |
| Boston Scientific Corporation | $53.09 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $33.90 | 2019-2021 | |
| Sanara Medtech INC. | $14.17 | 2025 | Biasurge |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Rabalais listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.